14 min listen
Drug Discovery with Machine Learning
FromData Skeptic
ratings:
Length:
29 minutes
Released:
Dec 21, 2018
Format:
Podcast episode
Description
In today's episode, Kyle chats with Alexander Zhebrak, CTO of Insilico Medicine, Inc. Insilico self describes as artificial intelligence for drug discovery, biomarker development, and aging research. The conversation in this episode explores the ways in which machine learning, in particular, deep learning, is contributing to the advancement of drug discovery. This happens not just through research but also through software development. Insilico works on data pipelines and tools like MOSES, a benchmarking platform to support research on machine learning for drug discovery. The MOSES platform provides a standardized benchmarking dataset, a set of open-sourced models with unified implementation, and metrics to evaluate and assess their performance.
Released:
Dec 21, 2018
Format:
Podcast episode
Titles in the series (100)
[MINI] Value of Information: A discussion about getting ready in the morning, negotiating a used car purchase, and selecting the best AirBnB place to stay at help frame a conversation about the decision theoretic principal known as the Value of Information equation. by Data Skeptic